X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (68) 68
female (55) 55
male (52) 52
index medicus (47) 47
adolescent (32) 32
adult (32) 32
child (25) 25
middle aged (24) 24
retrospective studies (22) 22
aged (21) 21
attention-deficit hyperactivity disorder (20) 20
children (20) 20
attention deficit disorder with hyperactivity - drug therapy (19) 19
adhd (16) 16
united states (15) 15
health care sciences & services (14) 14
medicine & public health (14) 14
prevalence (14) 14
adolescents (13) 13
aged, 80 and over (13) 13
quality of life (13) 13
treatment outcome (13) 13
care and treatment (12) 12
escitalopram (12) 12
health policy & services (12) 12
psychiatry (12) 12
research (12) 12
citalopram - therapeutic use (11) 11
comorbidity (11) 11
pharmacology & pharmacy (11) 11
attention deficit disorder with hyperactivity - economics (10) 10
double-blind (10) 10
analysis (9) 9
attention deficit disorder (9) 9
attention-deficit/hyperactivity disorder (9) 9
citalopram - economics (9) 9
cost-benefit analysis (9) 9
depressive disorder, major - drug therapy (9) 9
medicine, general & internal (9) 9
quality-of-life (9) 9
attention deficit disorder with hyperactivity - psychology (8) 8
attention deficit hyperactivity disorder (8) 8
central nervous system stimulants - therapeutic use (8) 8
clinical neurology (8) 8
costs (8) 8
deficit hyperactivity disorder (8) 8
drug therapy (8) 8
health economics (8) 8
internal medicine (8) 8
quality of life research (8) 8
serotonin uptake inhibitors - therapeutic use (8) 8
young adult (8) 8
caregivers (7) 7
chemotherapy (7) 7
diagnosis (7) 7
guanfacine (7) 7
health administration (7) 7
lisdexamfetamine dimesylate (7) 7
major depressive disorder (7) 7
medicine, research & experimental (7) 7
methylphenidate (7) 7
oncology (7) 7
pharmacoeconomics and health outcomes (7) 7
qualitative research (7) 7
serotonin uptake inhibitors - economics (7) 7
severity of illness index (7) 7
care (6) 6
central nervous system stimulants - administration & dosage (6) 6
cost (6) 6
depression (6) 6
original (6) 6
pediatrics (6) 6
public health, environmental and occupational health (6) 6
reproducibility of results (6) 6
adults (5) 5
attention deficit disorder with hyperactivity - epidemiology (5) 5
attention-deficit (5) 5
cancer (5) 5
central nervous system stimulants - economics (5) 5
clinical trials (5) 5
clinical-trials (5) 5
colony-stimulating factor (5) 5
cost of illness (5) 5
cost-effectiveness (5) 5
cost-utility (5) 5
costs and cost analysis (5) 5
delayed-action preparations (5) 5
depressive disorder, major - economics (5) 5
dextroamphetamine - therapeutic use (5) 5
disease (5) 5
double-blind method (5) 5
drug therapy, combination (5) 5
economics (5) 5
efficacy (5) 5
filgrastim (5) 5
guanfacine - therapeutic use (5) 5
health policy (5) 5
health services - utilization (5) 5
hospitalization (5) 5
hyperactivity disorder (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Health Economics, ISSN 1057-9230, 11/2017, Volume 26, Issue 11, pp. 1459 - 1466
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 05/2012, Volume 21, Issue 2, pp. 130 - 137
ABSTRACT Objectives To illustrate a matching‐adjusted indirect comparison by comparing the efficacy of guanfacine extended release (GXR) and atomoxetine (ATX)... 
comparative effectiveness | matching‐adjusted indirect comparison | oppositional defiant disorder (ODD) | nonstimulants | attention‐deficit/hyperactivity disorder (ADHD) | Matching-adjusted indirect comparison | Comparative effectiveness | Oppositional defiant disorder (ODD) | Nonstimulants | Attention-deficit/hyperactivity disorder (ADHD) | matching-adjusted indirect comparison | PLACEBO | NETWORK METAANALYSIS | CELL LUNG-CANCER | TECHNOLOGY-ASSESSMENT | MIXED TREATMENT COMPARISONS | hyperactivity disorder (ADHD) | ISPOR TASK-FORCE | CLINICAL-TRIALS | PHARMACOLOGY & PHARMACY | attention-deficit | META-REGRESSION | Attention Deficit and Disruptive Behavior Disorders - epidemiology | Randomized Controlled Trials as Topic - statistics & numerical data | Humans | Guanfacine - administration & dosage | Guanfacine - therapeutic use | Attention Deficit Disorder with Hyperactivity - drug therapy | Randomized Controlled Trials as Topic - standards | Attention Deficit and Disruptive Behavior Disorders - drug therapy | Pharmacoepidemiology - methods | Outcome and Process Assessment (Health Care) - statistics & numerical data | Comparative Effectiveness Research | Propylamines - therapeutic use | Propylamines - administration & dosage | Adolescent | Atomoxetine Hydrochloride | Attention Deficit Disorder with Hyperactivity - complications | Pharmacoepidemiology - statistics & numerical data | Attention Deficit and Disruptive Behavior Disorders - complications | Child | Delayed-Action Preparations | Attention Deficit Disorder with Hyperactivity - epidemiology | Psychotropic drugs | Attention deficit disorder | Clinical trials | Psychopharmacology | Child & adolescent psychiatry
Journal Article
Journal Article
Journal Article
Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, ISSN 1098-3015, 06/2017, Volume 20, Issue 6, p. 828
Journal Article
Neuropsychiatric Disease and Treatment, ISSN 1176-6328, 01/2017, Volume 13, p. 443
The caregiver perspective on pediatric attention-deficit/hyperactivity disorder (ADHD) study (CAPPA) was a web-based, cross-sectional survey of caregivers of... 
Caregivers | Analysis | Beliefs, opinions and attitudes | Attention-deficit hyperactivity disorder | Diagnosis | Drug therapy | Patient compliance | Risk factors
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 01/2015, Volume 24, Issue 1, pp. 27 - 37
Journal Article
Journal of medical economics, 04/2019, p. 1
To examine suboptimal response (SR) in attention deficit hyperactivity disorder (ADHD) among pediatric patients in the Texas Medicaid program receiving... 
Journal Article